Total Funding
61
48
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
124329
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
- Past Role: Truveris, Sr. VP Business Development
- Pablo Graiver: President and FounderPast Role: Kelkoo Group, Co-founder & VP Strategy
About the Company
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster.
Antidote was launched as TrialReach in 2010 and rebranded to
Antidote in 2016. The company is based in the US and the UK.
